Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073788 | SCV001239350 | likely pathogenic | Retinal dystrophy | 2018-02-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554678 | SCV003343990 | pathogenic | not provided | 2022-04-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys1437*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ABCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 866062). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |